Just my humble opinion and there are plenty of potential options...

Just my humble opinion and there are plenty of potential options for the company. As the share price appreciates Imugene will have the ability to self fund which will allow it to not sell out to the first bidder. I saw this work really well with Advanced Micro Devices when the stock moved up from a dollar a share to around 7 bucks and they bought a secondary offering which payed off all its high yielding debt and allowed it to have the funds for research. The stock is above $80 a share. Also Imugene trades on the Nasdaq pink sheets which is considered a backwater. They need to do a reverse split which would get the stock out of the penny stock category and list on the Nasdaq exchange. This will allow fund companies with stock price restrictions to buy.